Diagnostic and therapeutic uses of nanomaterials in the brain

Curr Med Chem. 2014;21(36):4100-31. doi: 10.2174/0929867321666140815124246.

Abstract

Nanomedicine has recently emerged as an exciting tool able to improve the early diagnosis and treatment of a variety of intractable or age-related brain disorders. The most relevant properties of nanomaterials are that they can be engineered to cross the blood brain barrier, to target specific cells and molecules and to act as vehicles for drugs. Potentially beneficial properties of nanotherapeutics derived from its unique characteristics include improved efficacy, safety, sensitivity and personalization compared to conventional medicines. In this review, recent advances in available nanostructures and nanomaterials for brain applications will be described. Then, the latest applications of nanotechnology for the diagnosis and treatment of neurological disorders, in particular brain tumors and neurodegenerative diseases, will be reviewed. Recent investigations of the neurotoxicity of the nanomaterial both in vitro and in vivo will be summarized. Finally, the ongoing challenges that have to be meet if new nanomedical products are to be put on the market will be discussed and some future directions will be outlined.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry
  • Blood-Brain Barrier / metabolism
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / drug therapy
  • Cell-Penetrating Peptides / chemistry
  • Cell-Penetrating Peptides / metabolism
  • Dopamine Agents / administration & dosage
  • Dopamine Agents / chemistry
  • Drug Carriers / chemistry
  • Humans
  • Nanomedicine
  • Nanostructures* / chemistry
  • Nanostructures* / therapeutic use
  • Nootropic Agents / administration & dosage
  • Nootropic Agents / chemistry
  • Parkinson Disease / diagnosis
  • Parkinson Disease / drug therapy

Substances

  • Antineoplastic Agents
  • Cell-Penetrating Peptides
  • Dopamine Agents
  • Drug Carriers
  • Nootropic Agents